Fortis to finally report its Q4 numbers today. Here#39;s what to expect
News2018-06-24
14 Views
Fortis is going through a severe cash crunch at the moment. The company#39;s debt was downgraded by rating agencies and borrowing more money hasn#39;t been easy
Latest News from Moneycontrol.com
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
FDA Approves Aurinia Pharmaceuticals' (Nasdaq: AUPH / TSX: AUP) LUPKYNIS (voclosporin) for Adult Patients with Active Lupus Nephritis
